In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brian Bossetta

Senior Writer, US Policy & Regulation

New York, NY
After moving to New York from his hometown of New Orleans, Brian worked on the East End of Long Island covering news, politics and the military. He has since covered the diamond and jewelry industries and most recently pharmacy and healthcare. His experience also includes freelance reporting and photography contributed to the New York Times.

Brian holds a BA in history from Loyola University of New Orleans, is a die-hard Saints fan, and loves running, classical music and jazz. He lives with his wife, Caroline, in New York’s magnificent Hudson Valley. 

Latest From Brian Bossetta

Medicare Proposes NTAP For Breakthrough Treatment Of Spinal Condition

US Medicare has granted a new technology add-on payment (NTAP) for an innovative technology designed to treat adult spinal deformity.

Medicare Reimbursement

First EUA In US For OTC Test To Detect COVID-19, Flu, RSV Granted To Labcorp

Agency issued an emergency use authorization to Labcorp for its OTC that detects COVID-19, flu and respiratory syncytial virus.

Coronavirus COVID-19 FDA

Senate Bill Establishes Greater Regulatory Oversight Of Lab Developed Tests

Draft legislation out of the US Senate Health, Education, Labor and Pensions (HELP) Committee gives the FDA authority to regulate certain in vitro diagnostics known as laboratory developed tests.

FDA In Vitro Diagnostics

FDA Grants EUA To First OTC Test That Detects COVID-19, Flu, RSV

The US agency has issued an emergency use authorization to Labcorp for its over-the-counter test that detects COVID-19, flu and respiratory syncytial virus.

FDA Coronavirus COVID-19

US To Share Its COVID-19 Technologies With World, Biden Says

During the second global COVID-19 summit, US President Joe Biden pledged to share essential technologies across the globe to fight the pandemic.

Coronavirus COVID-19 Vaccines

Industry Experts Give FDA’s Pre-Cert Program Thumbs-Up

A panel of industry experts gave the US FDA’s Digital Software Precertification Program the thumbs-up during a MedCon session.

FDA Digital Health
See All
UsernamePublicRestriction

Register